These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32015135)

  • 1. The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.
    Boyer DR; Li B; Sun C; Fan W; Zhou K; Hughes MP; Sawaya MR; Jiang L; Eisenberg DS
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3592-3602. PubMed ID: 32015135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles.
    Lee SS; Civitelli L; Parkkinen L
    Elife; 2024 Nov; 13():. PubMed ID: 39584804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study.
    Ma Y; Farris CM; Weber S; Schade S; Nguyen H; Pérez-Soriano A; Giraldo DM; Fernández M; Soto M; Cámara A; Painous C; Muñoz E; Valldeoriola F; Martí MJ; Clarimon J; Kallunki P; Ma TC; Alcalay RN; Gomes BF; Blennow K; Zetterberg H; Constantinescu J; Mengel D; Kadam V; Parchi P; Brockmann K; Tropea TF; Siderowf A; Synofzik M; Kang UJ; Compta Y; Svenningsson P; Mollenhauer B; Concha-Marambio L
    Lancet Neurol; 2024 Dec; 23(12):1225-1237. PubMed ID: 39577923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residues 2 to 7 of α-synuclein regulate amyloid formation via lipid-dependent and lipid-independent pathways.
    Dewison KM; Rowlinson B; Machin JM; Crossley JA; Thacker D; Wilkinson M; Ulamec SM; Khan GN; Ranson NA; van Oosten-Hawle P; Brockwell DJ; Radford SE
    Proc Natl Acad Sci U S A; 2024 Aug; 121(34):e2315006121. PubMed ID: 39133842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.
    Jones-Tabah J; He K; Karpilovsky N; Senkevich K; Deyab G; Pietrantonio I; Goiran T; Cousineau Y; Nikanorova D; Goldsmith T; Del Cid Pellitero E; Chen CX; Luo W; You Z; Abdian N; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Miliukhina I; Timofeeva A; Emelyanov A; Pchelina S; Greenbaum L; Hassin-Baer S; Alcalay RN; Milnerwood A; Durcan TM; Gan-Or Z; Fon EA
    Mol Neurodegener; 2024 Nov; 19(1):88. PubMed ID: 39587654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different charged biopolymers induce α-synuclein to form fibrils with distinct structures.
    Yao Y; Zhao Q; Tao Y; Liu K; Cao T; Chen Z; Liu C; Le W; Zhao J; Li D; Kang W
    J Biol Chem; 2024 Nov; 300(11):107862. PubMed ID: 39374778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.
    Schrempel S; Kottwitz AK; Piechotta A; Gnoth K; Büschgens L; Hartlage-Rübsamen M; Morawski M; Schenk M; Kleinschmidt M; Serrano GE; Beach TG; Rostagno A; Ghiso J; Heneka MT; Walter J; Wirths O; Schilling S; Roßner S
    Acta Neuropathol; 2024 Dec; 148(1):78. PubMed ID: 39625512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults.
    Huang Y; Trollor JN; Foley KR; Arnold SRC
    Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-synuclein prion strains differentially adapt after passage in mice.
    Holec SAM; Khedmatgozar CR; Schure SJ; Pham T; Woerman AL
    PLoS Pathog; 2024 Dec; 20(12):e1012746. PubMed ID: 39642110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Molecular Tweezer Binding on α-Synuclein with Native Top-Down Mass Spectrometry and Ion Mobility-Mass Spectrometry Reveals a Mechanism for Aggregation Inhibition.
    Lantz C; Lopez J; Goring AK; Zenaidee MA; Biggs K; Whitelegge JP; Ogorzalek Loo RR; Klärner FG; Schrader T; Bitan G; Loo JA
    J Am Soc Mass Spectrom; 2023 Dec; 34(12):2739-2747. PubMed ID: 37936057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults.
    Love AMA; Edwards C; Cai RY; Gibbs V
    Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New prospects for
    Wuensche TE; Pereira PM; Windhorst AD; Bjerregaard-Andersen K; Sotty F; Kallunki P; Jensen A; Bang-Andersen B; van Dongen GAMS; Beaino W; Vugts DJ
    Nucl Med Biol; 2024 Nov; 140-141():108969. PubMed ID: 39591759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics.
    Ganegamage SK; Ademoye TA; Patel H; Alnakhala H; Tripathi A; Nguyen CCD; Pham K; Plascencia-Villa G; Zhu X; Perry G; Tian S; Dettmer U; Lasagna-Reeves C; Fortin JS
    ACS Chem Neurosci; 2024 Nov; 15(21):3915-3931. PubMed ID: 39436010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers.
    McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT
    Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Potential of Biomimetic Peptides in Targeting Fibrillar and Filamentous Alpha-Synuclein-An In Silico and Experimental Approach to Parkinson's Disease.
    Frantzeskos SA; Biggs MA; Banerjee IA
    Biomimetics (Basel); 2024 Nov; 9(11):. PubMed ID: 39590277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best-of-both-worlds computational approaches to difficult-to-model dissociation reactions on metal surfaces.
    Kroes GJ; Meyer J
    Chem Sci; 2024 Nov; ():. PubMed ID: 39640030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.
    Kuang Y; Mao H; Huang X; Chen M; Dai W; Gan T; Wang J; Sun H; Lin H; Liu Q; Yang X; Xu PY
    Transl Neurodegener; 2024 Nov; 13(1):56. PubMed ID: 39574205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models).
    Toledano A; Rodríguez-Casado A; Älvarez MI; Toledano-Díaz A
    Brain Sci; 2024 Oct; 14(11):. PubMed ID: 39595866
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.